Hepatitis

The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.

Latest News

Atezolizumab, Bevacizumab is First Combination to Reduce Risk of Cancer Recurrence in Some Forms of Early-Stage Liver Cancer
Atezolizumab, Bevacizumab is First Combination to Reduce Risk of Cancer Recurrence in Some Forms of Early-Stage Liver Cancer

January 24th 2023

Overall survival data were immature at the time of interim analysis and follow-up will continue to the next analysis.

Study: Increased Coffee Consumption May Reduce Severity of Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes
Study: Increased Coffee Consumption May Reduce Severity of Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes

January 18th 2023

 Chronic Hepatitis B Patients in Africa Need Improved Diagnostic Tools, Study Results Show
Chronic Hepatitis B Patients in Africa Need Improved Diagnostic Tools, Study Results Show

January 11th 2023

Differentiating Features of Atypical Hepatocellular Carcinoma vs Intrahepatic Mass-Forming Cholangiocarcinoma in Contrast-Enhanced MRI
Differentiating Features of Atypical Hepatocellular Carcinoma vs Intrahepatic Mass-Forming Cholangiocarcinoma in Contrast-Enhanced MRI

January 9th 2023

Improved Access to Direct-acting Antivirals Lowers Hepatitis C Incidence Rates
Improved Access to Direct-acting Antivirals Lowers Hepatitis C Incidence Rates

January 3rd 2023

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.